Dementia rates fell 30% over 16 years — working and education may deserve credit
(By Mariah Taylor for Becker’s Hospital Review) Researchers from RAND Corporation, a nonprofit think tank, found dementia rates dropped by
Read More
Alzheimer’s/Dementia
Depression And Alzheimer’s Treatments At A Crossroads
(By Jon Hamilton and Aaron Scott for NPR) Researchers are launching a make-or-break study to test the conventional wisdom about
Read MoreSupreme Court to Hear Nursing Home Case That Could Affect Millions
(By Farah Yousry, Side Effects Public Media for Kaiser Health News) When Susie Talevski sued the agency that managed her
Read More‘Front of the line’: For Alzheimer’s patients in successful trial, a feeling of gratitude
(By Andrew Joseph for Stat News dated October 20, 2022) When the news came out last month that an experimental
Read More‘Front of the line’: For Alzheimer’s patients in successful trial, a feeling of gratitude
(By Andrew Joseph for STAT) When the news came out last month that an experimental Alzheimer’s therapy succeeded in a
Read MoreFDA approves ALS drug from Amylyx, giving patients a much-needed treatment option
(By Damian Garde for STAT) The Food and Drug Administration approved a new medicine for ALS from Amylyx Pharmaceuticals on
Read MoreAn Alzheimer’s therapy scores winning results, but what could it mean for patients?
(By Andrew Joseph for STAT) The news Tuesday night that a clinical trial of an experimental Alzheimer’s therapy had succeeded
Read MoreClearing Pollution Helps Clear the Fog of Aging — And May Cut the Risk of Dementia
(By Judith Graham for Kaiser Health News) During the past decade, a growing body of research has shown that air
Read MoreCOVID-19 tied to higher Alzheimer’s risk in seniors, study suggests
(By Mackenzie Bean for Becker’s Hospital Review) Adults 65 and older who contract COVID-19 may be at greater risk for
Read MoreDaily multivitamins improved the brain function of seniors in a trial — but plenty of questions remain
By Jonathan Wosen for STAT News on September 14, 2022 While pharma companies struggle to show that cutting-edge therapies can
Read More